TY - JOUR
T1 - Candida albicans Enhances the Progression of Oral Squamous Cell Carcinoma In Vitro and In Vivo
AU - Vadovics, Máté
AU - Ho, Jemima
AU - Igaz, Nóra
AU - Alföldi, Róbert
AU - Rakk, Dávid
AU - Veres, Eva
AU - Szücs, Balázs
AU - Horváth, Márton
AU - Tóth, Renáta
AU - Szücs, Attila
AU - Csibi, Andrea
AU - Horváth, Péter
AU - Tiszlavicz, László
AU - Vágvölgyi, Csaba
AU - Nosanchuk, Joshua D.
AU - Szekeres, András
AU - Kiricsi, Mónika
AU - Henley-Smith, Rhonda
AU - Moyes, David L.
AU - Thavaraj, Selvam
AU - Brown, Rhys
AU - Puskás, László G.
AU - Naglik, Julian R.
AU - Gácser, Attila
N1 - Funding Information:
This work was supported by grant no. 20391-3/2018/FEKUSTRAT, NKFIH K 123952, LP2018-15/2018, and ÚNKP-20-5-SZTE-655 (M.K.) from the New National Excellence Program of the Ministry for Innovation and Technology from the National Research, Development, and Innovation Fund; by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences (grant no. BO/00878/19/8 to M.K.); and by the National Research, Development, and Innovation Office-NKFIH through project no. GINOP-2.3.2-15-2016-00038 and GINOP-2.3.2-15-2016-00035. The project also received funding from the EU’s Horizon 2020 research and innovation program under grant agreement no. 739593. J.R.N. was supported by the Wellcome Trust (grant no. 214229_Z_18_Z). R.T. was financed by the National Research, Development and Innovation Office–NKFIH through grant no. PD 138450.
Publisher Copyright:
Copyright © 2022 Vadovics et al.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Oral squamous cell carcinoma (OSCC) is associated with oral Candida albicans infection, although it is unclear whether the fungus promotes the genesis and progression of OSCC or whether cancer facilitates fungal growth. In this study, we investigated whether C. albicans can potentiate OSCC tumor development and progression. In vitro, the presence of live C. albicans, but not Candida parapsilosis, enhanced the progression of OSCC by stimulating the production of matrix metalloproteinases, oncometabolites, protumor signaling pathways, and overexpression of prognostic marker genes associated with metastatic events. C. albicans also upregulated oncogenes in nonmalignant cells. Using a newly established xenograft in vivo mouse model to investigate OSCC-C. albicans interactions, oral candidiasis enhanced the progression of OSCC through inflammation and induced the overexpression of metastatic genes and significant changes in markers of the epithelial-mesenchymal transition. Finally, using the 4-nitroquinoline 1-oxide (4NQO) murine model, we directly correlate these in vitro and short-term in vivo findings with the progression of oncogenesis over the long term. Taken together, these data indicate that C. albicans upregulates oncogenes, potentiates a premalignant phenotype, and is involved in early and late stages of malignant promotion and progression of oral cancer. IMPORTANCE Oral squamous cell carcinoma (OSCC) is a serious health issue worldwide that accounts for 2% to 4% of all cancer cases. Previous studies have revealed a higher yeast carriage and diversity in oral cancer patients than in healthy individuals. Furthermore, fungal colonization in the oral cavity bearing OSCC is higher on the neoplastic epithelial surface than on adjacent healthy surfaces, indicating a positive association between oral yeast carriage and epithelial carcinoma. In addition to this, there is strong evidence supporting the idea that Candida contributes to carcinogenesis events in the oral cavity. Here, we show that an increase in Candida albicans burden promotes an oncogenic phenotype in the oral cavity.
AB - Oral squamous cell carcinoma (OSCC) is associated with oral Candida albicans infection, although it is unclear whether the fungus promotes the genesis and progression of OSCC or whether cancer facilitates fungal growth. In this study, we investigated whether C. albicans can potentiate OSCC tumor development and progression. In vitro, the presence of live C. albicans, but not Candida parapsilosis, enhanced the progression of OSCC by stimulating the production of matrix metalloproteinases, oncometabolites, protumor signaling pathways, and overexpression of prognostic marker genes associated with metastatic events. C. albicans also upregulated oncogenes in nonmalignant cells. Using a newly established xenograft in vivo mouse model to investigate OSCC-C. albicans interactions, oral candidiasis enhanced the progression of OSCC through inflammation and induced the overexpression of metastatic genes and significant changes in markers of the epithelial-mesenchymal transition. Finally, using the 4-nitroquinoline 1-oxide (4NQO) murine model, we directly correlate these in vitro and short-term in vivo findings with the progression of oncogenesis over the long term. Taken together, these data indicate that C. albicans upregulates oncogenes, potentiates a premalignant phenotype, and is involved in early and late stages of malignant promotion and progression of oral cancer. IMPORTANCE Oral squamous cell carcinoma (OSCC) is a serious health issue worldwide that accounts for 2% to 4% of all cancer cases. Previous studies have revealed a higher yeast carriage and diversity in oral cancer patients than in healthy individuals. Furthermore, fungal colonization in the oral cavity bearing OSCC is higher on the neoplastic epithelial surface than on adjacent healthy surfaces, indicating a positive association between oral yeast carriage and epithelial carcinoma. In addition to this, there is strong evidence supporting the idea that Candida contributes to carcinogenesis events in the oral cavity. Here, we show that an increase in Candida albicans burden promotes an oncogenic phenotype in the oral cavity.
KW - Cancer
KW - Candida albicans
KW - Oral squamous cell carcinoma
KW - Progression
UR - http://www.scopus.com/inward/record.url?scp=85125900162&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125900162&partnerID=8YFLogxK
U2 - 10.1128/MBIO.03144-21
DO - 10.1128/MBIO.03144-21
M3 - Article
C2 - 35089096
AN - SCOPUS:85125900162
SN - 2161-2129
VL - 13
JO - mBio
JF - mBio
IS - 1
M1 - e03144
ER -